|
Volumn 83, Issue 10, 2000, Pages 1375-1379
|
Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate 211At-rituximab against non-Hodgkin's lymphoma cells
|
Author keywords
Bone marrow; Clonogenic survival; Lymphoma cells; Radioimmunoconjugate; Rituximab; Emitter
|
Indexed keywords
RADIOPHARMACEUTICAL AGENT;
RITUXIMAB;
RITUXIMAB ASTATINE AT 211;
UNCLASSIFIED DRUG;
ALPHA RADIATION;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
B CELL LYMPHOMA;
BONE MARROW CELL;
CELL SURVIVAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG DISTRIBUTION;
HEMATOPOIETIC STEM CELL;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
ISOTOPE LABELING;
LYMPHOMA CELL LINE;
MOUSE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
|
EID: 0033742754
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1054/bjoc.2000.1453 Document Type: Article |
Times cited : (45)
|
References (25)
|